Verseon Corporation Additional Listing & Total Voting Rights (1596T)
2018年7月2日 - 3:00PM
ＲＮＳを含む英国規制内ニュース （英語）
TIDMVSN
RNS Number : 1596T
Verseon Corporation
02 July 2018
July 2, 2018
Verseon Corporation
("Verseon" or the "Company")
Additional Listing & Total Voting Rights
Fremont, Calif.-Verseon, a technology-based pharmaceutical
company, announces that application has been made for 18,072 new
shares of common stock ("Common Shares") of par value $0.001 each
to be admitted to trading on AIM pursuant to regularly scheduled
vesting of restricted stock units (the "Issuance"). The restricted
stock units ("RSU") have been issued to Dr. Thomas Hecht and Dr.
Robert Karr, both non-executive Directors of the Company, in
relation to the payment of their Director's fees as previously
disclosed. Of the 18,072 Common Shares issued, 9,036 Common Shares
were issued to Dr. Hecht and 9,036 to Dr. Karr.
Following the Issuance, Dr. Hecht will hold 81,472 Common
Shares, representing 0.05% of the Company's issued share capital.
Dr. Karr will hold 209,360 Common Shares, representing 0.14% of the
Company's issued share capital.
The 18,072 new Common Shares issued pursuant to the Issuance
will rank pari passu with the Company's existing Common Shares and
admission to trading on AIM is expected to take place on July 6,
2018 ("Admission").
Total Voting Rights
Following Admission, the issued share capital of the Company
will consist of 151,618,042 Common Shares and the Company will hold
42,917 shares in treasury. Therefore, the total number of Common
Shares in the Company with voting rights will be 151,575,125. This
figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's
Disclosure and Transparency Rules.
For further information, please contact:
Verseon Corporation www.verseon.com
Sebastian Wykeham / Tina Schlafly +1 (510) 225 9000
Cenkos Securities (NOMAD and Joint
Broker)
+44 (0) 20 7397
Neil McDonald / Beth McKiernan 8900
Cantor Fitzgerald Europe (Joint Broker)
+44 (0) 20 7894
Marc Milmo / Phil Davies 7000
For financial and business media enquiries, please contact
Buchanan Communications Ltd (PR Advisers)
+44 (0) 20 7466
Henry Harrison-Topham / Jamie Hooper 5000
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737 821
Simon Vane Percy 890
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Dr. Thomas Hecht
------------------------------ ------------------------------------
2 Reason for the notification
--------------------------------------------------------------------
a) Position/status Non-Executive Chairman
------------------------------ ------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ ------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name Verseon Corporation
------------------------------ ------------------------------------
b) LEI 213800CB2DUHDL6EPW12
------------------------------ ------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------
a) Description of the Restricted stock grant of Common
financial instrument, Shares of par value $0.001
type of instrument
Identification code ISIN: USU9221J1098
------------------------------ ------------------------------------
b) Nature of the transaction Vesting of restricted stock units
------------------------------ ------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
- 9,036
----------
------------------------------ ------------------------------------
Aggregated information
- Aggregated volume 9,036
d) - Price -
------------------------------ ------------------------------------
e) Date of the transaction 30 June 2018
------------------------------ ------------------------------------
f) Place of the transaction N/a
------------------------------ ------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Dr. Robert Karr
------------------------------ ------------------------------------
2 Reason for the notification
--------------------------------------------------------------------
a) Position/status Non-Executive Chairman
------------------------------ ------------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ ------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name Verseon Corporation
------------------------------ ------------------------------------
b) LEI 213800CB2DUHDL6EPW12
------------------------------ ------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
--------------------------------------------------------------------
a) Description of the Restricted stock grant of Common
financial instrument, Shares of par value $0.001
type of instrument
Identification code ISIN: USU9221J1098
------------------------------ ------------------------------------
b) Nature of the transaction Vesting of restricted stock units
------------------------------ ------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
- 9,036
----------
------------------------------ ------------------------------------
Aggregated information
- Aggregated volume 9,036
d) - Price -
------------------------------ ------------------------------------
e) Date of the transaction 30 June 2018
------------------------------ ------------------------------------
f) Place of the transaction N/a
------------------------------ ------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCEADXFEFNPEFF
(END) Dow Jones Newswires
July 02, 2018 02:00 ET (06:00 GMT)
Verseon (LSE:VSN)
過去 株価チャート
から 5 2024 まで 6 2024
Verseon (LSE:VSN)
過去 株価チャート
から 6 2023 まで 6 2024
